Medi Caps Ltd (MEDICAPQ) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Medi Caps Ltd on NSE and BSE, with an AI summary of each filing.
Submission of unaudited standalone & Consolidated Financial Results for the quarter & Half year ended 30.09.2026
Financial Result · 04 Nov 2026, 10:38 pm
Submission of Unaudited Standalone & Consolidated financial Result for the quarter and half year ended 30.09.2026
Outcome · 04 Nov 2026, 10:28 pm
Medi Caps Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 577 (+186.9% YoY | +107.2% QoQ) ■ EBITDA: 33.7 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 5.8 (Loss to Profit YoY | Loss to Profit QoQ) ■ PAT: -8.8 (+95.2% YoY | +96.1% QoQ) ■ EPS (INR): -0.07 (+95.2% YoY | +96.1% QoQ) Medi Caps Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Pharma Division ■ Revenue: 565 (+458.1% YoY | +110.7% QoQ) ■ EBIT: 43.9 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 7.8 (Loss to Profit YoY | Loss to Profit QoQ) Real Estate Division ■ Revenue: 12.3 (-87.7% YoY | +17.0% QoQ) ■ EBIT: -52.7 (Profit to Loss YoY | +10.7% QoQ) ■ EBIT Margin (%): -429 (Profit to Loss YoY | +13272 bps QoQ)
Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve 1.Consider and approve the Standalone ....
Intimation · 04 Nov 2026, 5:30 am
Medi-Caps Schedules Board Meeting for Q2 FY27 Results Medi-Caps Limited has scheduled its Board of Directors meeting for 4th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26, alongside the limited review report. In compliance with insider trading regulations, the trading window for dealing in company securities will reopen 48 hours post the declaration of the financial results for all designated persons and connected insiders.
Continues disclosers for events transected and approved with requisite majority of member in 43rd AGM
Annual General Meeting · 23 Sept 2026, 9:31 pm
Voting Results along with Scrutinizer"s Report of 43rd AGM dated 22nd September, 2026
Annual General Meeting · 23 Sept 2026, 9:13 pm
Submission of Proceedings of 43rd Annual General Meeting.
Annual General Meeting · 22 Sept 2026, 10:24 pm
Information under Regulation 44 of SEBI (LODR) Regulation, 2015 and Section 108 of Companies Act, 2013 regarding E-Voting through electronic mode for the 43rd Annual General Meeting to ....
Annual General Meeting · 25 Aug 2026, 5:54 pm
Intimation for dispatch of letter to those shareholders whose email addresses are not registered with company/registrar & transfer agent/Depository Participants.
Others (Uncategorized) · 25 Aug 2026, 5:47 pm
Medi-Caps Schedules 43rd AGM for Sep '26; Notifies on Annual Report Medi-Caps Limited (BSE: 523144) will hold its 43rd Annual General Meeting (AGM) via video conference on 22nd Sep'26 at 12:30 p.m. The company has informed the exchange on 25th Aug'26 that it is dispatching letters to shareholders whose email addresses are not registered. This communication provides a web link to access the Annual Report for the financial year ended 31st Mar'26. The report and AGM notice are available on the company's website, BSE, and CDSL's e-voting platform.
Submission of 43rd Annual Report for the Financial Year 2025-26 pursuant to Regulation 34 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015
Others (Uncategorized) · 25 Aug 2026, 5:39 pm
Submission of Notice of 43rd Annual General Meeting scheduled to be held on 22nd September, 2026 at 12:30 PM (IST) through Video Conference (VC)/Other audio Visual means (OAVM).
Annual General Meeting · 25 Aug 2026, 5:17 pm
Pursuant to the requirement of regulation 30 (5) of SEBI (LODR), Regulation 2015, authorization to the person for the purpose of demining the materiality of event or information and for ....
Others (Uncategorized) · 08 Aug 2026, 8:53 pm
Medi-Caps Announces Key Management and Board Changes Medi-Caps Limited announced significant leadership changes, including the resignation of Chairperson and Non-Executive Non-Independent Director Mr. Ramesh Chandra Mittal, effective 06 Aug'26. Mr. Hemant Sethi also resigned as Chief Financial Officer (CFO), effective 06 Jun'26. Following this, Mr. Akshit Garg has been appointed as the new CFO and Key Managerial Personnel (KMP), with his role commencing on 07 Aug'26. The company has also re-authorized its KMPs for materiality determination and stock exchange disclosures.
Resignation of Mr. Akshit Garg, From the post of General Manager & Senior management personnel and Mrs. Saloni Garg, from the post of Senior Manager & senior management personnel w.e.f. 06.08.2026
Change in Management · 06 Aug 2026, 10:42 pm
Medi-Caps Announces Senior Management Resignations and Internal Promotions Medi-Caps Limited announced two senior management resignations effective 06th Aug'26. Saloni Garg has resigned as Senior Manager to become Additional Director & Whole Time Woman Director. Akshit Garg resigned as General Manager and will be appointed Chief Financial Officer (CFO) & Key Managerial Personnel (KMP). Both resignations are due to these internal promotions, with the company confirming no other material reasons for the changes. The moves represent a key restructuring of the company's board and senior leadership team.
Appointment of Mrs. Saloni Garg as additional and Whole time woman director of the company w.e.f. 07.08.2026
Change in Management · 06 Aug 2026, 10:38 pm
Medi-Caps Announces Key Management Appointments and MD Re-appointment Medi-Caps Limited's board approved key leadership changes on 06 Aug'26. Mr. Alok K. Garg was re-appointed as Chairman and Managing Director for a three-year term, effective 01 Sep'26 to 31 Aug'29. The company appointed Mr. Akshit Garg as the new Chief Financial Officer (CFO) and Mrs. Saloni Garg as an Additional and Whole-Time Woman Director, both effective 07 Aug'26. The appointments of Mr. Alok Garg and Mrs. Saloni Garg are subject to shareholder approval at the upcoming 43rd Annual General Meeting.
Appointment of Mr. Alok K. Garg as chairman cum Managing Director of the Company w.e.f. 01.09.2026
Change in Management · 06 Aug 2026, 10:37 pm
Medi-Caps Announces Key Board Appointments and Management Changes Medi-Caps Limited's board approved several key appointments on 06 Aug'26. Mr. Alok K. Garg was re-appointed as Chairman & Managing Director for three years, effective 01 Sep'26. Mr. Akshit Garg was appointed as Chief Financial Officer (CFO) and Key Managerial Personnel, effective 07 Aug'26. Additionally, Mrs. Saloni Garg was appointed as an Additional Director and Whole-Time Woman Director for a three-year term, also effective 07 Aug'26. All director appointments are subject to shareholder approval at the 43rd AGM.
Appointment of Mr. Akshit Garg as Chief Financial officer (CFO) of the Company w.e.f. 07.08.2026
Change in Management · 06 Aug 2026, 10:34 pm
Medi-Caps Announces Key Leadership Appointments and Re-appointment The Board of Directors re-appointed Mr. Alok K. Garg as Chairman & Managing Director for three years, from 01st Sep'26 to 31st Aug'29. Additionally, Mr. Akshit Garg has been appointed as Chief Financial Officer (CFO) and Key Managerial Personnel, effective 07th Aug'26. Mrs. Saloni Garg has been appointed as an Additional Director and Whole-Time Woman Director for a three-year term starting 07th Aug'26. The re-appointment of Mr. Garg and appointment of Mrs. Garg are subject to shareholder approval.
Submission of unaudited standalone and consolidated financial results for the quarter ended on 30.06.2026 as approved by The board of the directors in its meeting held on 06.08.2026
Financial Result · 06 Aug 2026, 10:24 pm
Medi-Caps Reports Q1FY27 Results and Announces Key Management Changes Medi-Caps reported Q1FY27 consolidated results with revenue from operations at ₹278.69 Lacs and a net loss of ₹223.29 Lacs, compared to a loss of ₹349.19 Lacs YoY. EPS stood at ₹-1.79 versus ₹-2.80 YoY. The board approved Q1 results for the quarter ended 30th Jun'26. Key appointments effective 07th Aug'26 include Mrs. Saloni Garg as Additional & Whole Time Woman Director and Mr. Akshit Garg as CFO. Mr. Alok K. Garg was re-appointed as Chairman & MD for three years from 01st Sep'26.
Outcome of the meeting of the board of directors held on 06.08.2026
Outcome · 06 Aug 2026, 10:18 pm
Medi Caps Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) ■ Revenue: 279 (+3.7% YoY | -19.2% QoQ) ■ EBITDA: -183 (+45.7% YoY | +11.1% QoQ) ■ EBITDA Margin (%): -65.7 (+5990 bps YoY | -601 bps QoQ) ■ PAT: -223 (+36.1% YoY | Profit to Loss QoQ) ■ EPS (INR): -1.79 (+36.1% YoY | Profit to Loss QoQ) Medi Caps Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) Segmental Performance Pharma Division ■ Revenue: 268 (-0.2% YoY | -8.0% QoQ) ■ EBIT: -164 (+46.7% YoY | Profit to Loss QoQ) ■ EBIT Margin (%): -61.3 (+5338 bps YoY | Profit to Loss QoQ) Real Estate Division ■ Revenue: 10.5 (-80.3% QoQ) ■ EBIT: -59.0 (-48.3% YoY | -80.1% QoQ) ■ EBIT Margin (%): -562 (-50071 bps QoQ) Other ■ Revenue: 0.0 ■ EBIT: 0.0 ■ EBIT Margin (%): 0.0
Intimation received for resignation of Mr. Ramesh Chandra Mittal as a chairman of the company.
Change in Management · 30 Jul 2026, 6:53 pm
Medi-Caps Chairman and Director Resign Citing Health Concerns Medi-Caps Limited (BSE: 523144) announced the resignation of two key board members effective 06 Aug'26. Mr. Ramesh Chandra Mittal has resigned from his roles as Chairperson and Non-Executive Non-Independent Director. Simultaneously, Mrs. Kusum Mittal has stepped down as a Non-Executive Non-Independent Director. Both resignations are attributed to personal health concerns. The company confirmed there are no other material reasons for their departures. The board will formally consider the resignations at its next meeting.
Intimation for resignation of Non executive director Mr. Ramesh Chandra Mittal and Kusum Mittal .
Change in Management · 30 Jul 2026, 6:47 pm
Medi-Caps Chairperson and Director Resign Citing Health Reasons Medi-Caps Limited announced the resignations of Chairperson Ramesh Chandra Mittal and Director Kusum Mittal, effective 06th Aug'26. Mr. Mittal stepped down from his roles as Chairperson and Non-Executive Non-Independent Director, while Mrs. Mittal resigned as Non-Executive Non-Independent Director. Both cited personal health concerns as the reason for their departure. The company confirmed there are no other material reasons for the resignations, which will be formally accepted at the next board meeting.
Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve 1.Consider and approve the Standalone ....
Intimation · 06 Aug 2026, 5:30 am
Medi-Caps Board to Review Q1FY27 Results on 06-Aug-26 Medi-Caps Limited scheduled a Board of Directors meeting for 06-Aug-26 to consider and approve the standalone and consolidated un-audited financial results for the quarter ended 30-Jun-26. The trading window for designated persons will reopen 48 hours after the declaration of these financial results.
Please find enclosed intimation regarding resignation of Chief Financial Officer.
Change in Management · 08 Jun 2026, 4:35 pm
Medi-Caps CFO & KMP Hemant Sethi Resigns Medi-Caps Limited announced that Mr. Hemant Sethi has resigned from his position as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective from the close of business hours on 06th Jun'26. The company filing, dated 08th Jun'26, cites his decision to pursue career growth and professional opportunities as the reason for departure. Mr. Sethi confirmed no other material reasons for his resignation. The resignation letter will be presented to the Board of Directors for formal acceptance in their upcoming meeting.
Re-appointment of internal Auditor for the financial year 2026-27
Change in Management · 21 May 2026, 9:57 pm
Medi-Caps Re-appoints Praveen Shrivastava & Co. as Internal Auditor for FY27 Medi-Caps Limited re-appointed Praveen Shrivastava & Company, Chartered Accountants, as its Internal Auditor effective 21st May'26. The appointment covers the financial year 2026-27. Praveen Shrivastava & Co. is a 15-year-old firm with significant experience providing internal audit services to Indian corporates, particularly in the manufacturing sector. This reappointment ensures continuity in the company's internal audit function and corporate governance framework. The decision was made in compliance with SEBI (LODR) Regulations and the Companies Act, 2013.
Submission of audited standalone and consolidated financial results for the quarter and year ended 31.03.2026
Financial Result · 21 May 2026, 9:48 pm
Medi-Caps Reports FY26 Loss Amidst Challenging Market Conditions Medi-Caps reported Q4FY26 and FY26 audited results on 21 May'26. On a consolidated basis for FY26, the company posted a net loss of ₹303.75 Lacs versus a loss of ₹57.10 Lacs YoY, on revenue of ₹1,244.85 Lacs, down from ₹2,547.71 Lacs. The full-year loss was attributed to unstable political conditions in the USA market. For Q4FY26, consolidated PBT stood at ₹302.74 Lacs against ₹144.83 Lacs YoY. The auditors issued an unmodified opinion. The board also re-appointed the internal auditor for FY27.
With reference to the above captioned subject and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that, Board ....
Outcome · 21 May 2026, 9:42 pm
Medi Caps Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) ■ Revenue: 345 (-50.5% YoY | -19.8% QoQ) ■ EBITDA: -206 (-819.5% YoY | -94.5% QoQ) ■ EBITDA Margin (%): -59.7 (-5652 bps YoY | -3510 bps QoQ) ■ PAT: 304 (+77.0% YoY | Loss to Profit QoQ) ■ EPS (INR): 2.44 (+76.8% YoY | Loss to Profit QoQ) Medi Caps Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) Segmental Performance Pharma Division ■ Revenue: 292 (-52.0% YoY | -17.3% QoQ) ■ EBIT: 335 (+223.5% YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 115 (+9797 bps YoY | Loss to Profit QoQ) Real Estate Division ■ Revenue: 53.4 (-40.1% YoY | -31.0% QoQ) ■ EBIT: -32.7 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBIT Margin (%): -61.3 (Profit to Loss YoY | Profit to Loss QoQ) Other ■ Revenue: 0.0 ■ EBIT: 0.0 ■ EBIT Margin (%): 0.0
Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1.Consider and approve the Standalone ....
Intimation · 21 May 2026, 5:30 am
Medi-Caps Schedules Board Meeting for Q4 and FY26 Results Medi-Caps Ltd has scheduled a Board of Directors meeting for 21 May'26 to consider and approve its standalone and consolidated audited financial results for the fourth quarter and financial year ended 31 Mar'26. The agenda includes reviewing the auditor's report and discussing other routine matters. The trading window for insiders will reopen 48 hours after the declaration of the financial results.